5 Oversold MidCap Stocks To Buy

Page 5 of 5

1. Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Latest 14 Day RSI Score: 11.77

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is a biotechnology company that develops treatments for immune system and inflammation diseases. The firm’s shares sank by quite a bit in July after its treatment for an eye disease led to inflammation in patients’ eyes. However, the firm did beat its Q2 EPS analyst estimates by quite a bit, but JPMorgan and BofA have both recently downgraded the shares.

42 of the 943 hedge funds surveyed by Insider Monkey for their Q1 2023 investments had invested in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS). Kurt Von Emster’s VenBio Select Advisor is the biggest investor with a $732 million stake.

Follow Apellis Pharmaceuticals Inc. (NASDAQ:APLS)

Disclosure: None. You can also take a look at 10 Best August Dividend Stocks To Buy and 15 High Growth Large Cap Stocks to Invest In.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5